XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Subscription Receivable
Accumulated Deficit
Accumulated Other Comprehensive Income
Total GD Culture Group Limited Shareholders’ Deficits
Non controlling Interest
Total
Balance at Dec. 31, 2023 $ 545 $ 77,530,221   $ (69,358,225) $ 175,306 $ 8,347,847 $ 3,813,636 $ 12,161,483
Balance (in Shares) at Dec. 31, 2023 5,453,416              
Net loss   (3,978,628) (3,978,628) (178,911) (4,157,539)
Exercise of November 2023 Registered Warrants $ 71 (71)  
Exercise of November 2023 Registered Warrants (in Shares)   709,877              
Issuance of common stock for acquisition $ 40 3,150,753   3,150,793 (3,150,793)
Issuance of common stock for acquisition (in Shares)   400,000              
Issuance of common stock for cash $ 81 829,798   829,879 829,879
Issuance of common stock for cash (in Shares)   810,277              
Exercise of pre-funded warrants $ 57 597   654 654
Exercise of pre-funded warrants (in Shares)   567,691              
Foreign currency translation   78,891 78,891 (94,000) (15,109)
Fair value changes of convertible notes receivable   54,849 54,849 54,849
Balance at Mar. 31, 2024 $ 794 81,511,298   (73,336,853) 309,046 8,484,285 389,932 8,874,217
Balance (in Shares) at Mar. 31, 2024 7,941,261              
Balance at Dec. 31, 2023 $ 545 77,530,221   (69,358,225) 175,306 8,347,847 3,813,636 12,161,483
Balance (in Shares) at Dec. 31, 2023 5,453,416              
Net loss                 (7,750,451)
Fair value changes of convertible notes receivable                 (39,063)
Balance at Jun. 30, 2024 $ 950 82,759,142   (76,922,034) 211,613 6,049,671 380,920 6,430,591
Balance (in Shares) at Jun. 30, 2024 9,501,261              
Balance at Mar. 31, 2024 $ 794 81,511,298   (73,336,853) 309,046 8,484,285 389,932 8,874,217
Balance (in Shares) at Mar. 31, 2024 7,941,261              
Net loss   (3,585,181) (3,585,181) (7,731) (3,592,912)
Issuance of common stock for acquisition $ 156 1,247,844   1,248,000 1,248,000
Issuance of common stock for acquisition (in Shares)   1,560,000              
Foreign currency translation   (3,521) (3,521) (1,281) (4,802)
Fair value changes of convertible notes receivable   (93,912) (93,912) (93,912)
Balance at Jun. 30, 2024 $ 950 82,759,142   (76,922,034) 211,613 6,049,671 380,920 6,430,591
Balance (in Shares) at Jun. 30, 2024 9,501,261              
Balance at Dec. 31, 2024 $ 1,117 82,758,975 (83,194,386) 152,585 (281,709) 284,352 2,643
Balance (in Shares) at Dec. 31, 2024 11,167,294              
Net loss (977,510) (977,510) (977,510)
Issuance of common stock for cash $ 111 909,889 910,000 910,000
Issuance of common stock for cash (in Shares)   1,115,600              
Foreign currency translation 4 4 2 6
Balance at Mar. 31, 2025 $ 1,228 83,668,864 (84,171,896) 152,589 (349,215) 284,354 (64,861)
Balance (in Shares) at Mar. 31, 2025 12,282,894              
Balance at Dec. 31, 2024 $ 1,117 82,758,975 (83,194,386) 152,585 (281,709) 284,352 2,643
Balance (in Shares) at Dec. 31, 2024 11,167,294              
Net loss                 (2,476,564)
Fair value changes of convertible notes receivable                
Balance at Jun. 30, 2025 $ 1,680 93,813,211 (17,390) (85,670,950) 152,602 8,279,153 284,359 8,563,512
Balance (in Shares) at Jun. 30, 2025 16,795,433              
Balance at Mar. 31, 2025 $ 1,228 83,668,864 (84,171,896) 152,589 (349,215) 284,354 (64,861)
Balance (in Shares) at Mar. 31, 2025 12,282,894              
Net loss (1,499,054) (1,499,054) (1,499,054)
Issuance of prefunded warrants for cash 3,615,226 (17,390) 3,597,836 3,597,836
Exercise of November 2023 Registered Warrants $ 95 (95)
Exercise of November 2023 Registered Warrants (in Shares)   952,644              
Issuance of common stock for acquisition $ 245 5,988,278 5,988,523 5,988,523
Issuance of common stock for acquisition (in Shares)   2,444,295              
Issuance of common stock for cash $ 112 540,938 541,050 541,050
Issuance of common stock for cash (in Shares)   1,115,600              
Foreign currency translation 13 13 5 18
Fair value changes of convertible notes receivable                
Balance at Jun. 30, 2025 $ 1,680 $ 93,813,211 $ (17,390) $ (85,670,950) $ 152,602 $ 8,279,153 $ 284,359 $ 8,563,512
Balance (in Shares) at Jun. 30, 2025 16,795,433